LexDanaLexDanabeta
Inventor

CHUN-TSUNG LO

Inventor
TW

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
11,564,908Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder202311,419,852Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to GLYCOLYSIS BIOMED CO LTD (2)· patent assignee history
2022–2023Based in TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GLYCOLYSIS BIOMED CO LTD22022–2023
Locations
LocationPatentsSpan
TW22022–2023